Celcuity Inc. (CELC)
Largest Insider Buys in Sector
CELC Stock Price History Chart
CELC Stock Performance
About Celcuity Inc.
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Insider Activity of Celcuity Inc.
Over the last 12 months, insiders at Celcuity Inc. have bought $0 and sold $399,653 worth of Celcuity Inc. stock.
On average, over the past 5 years, insiders at Celcuity Inc. have bought $850,494 and sold $148,316 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $103,187 was made by Furcht Leo (director) on 2023‑05‑22.
List of Insider Buy and Sell Transactions, Celcuity Inc.
| 2024-06-21 | Sale | Buller Richard E | director | 350 0.0011% | $15.68 | $5,488 | +4.05% | |
| 2024-04-24 | Sale | Buller Richard E | director | 350 0.0011% | $17.06 | $5,971 | -6.23% | |
| 2024-02-21 | Sale | Buller Richard E | director | 350 0.0014% | $14.15 | $4,953 | +19.13% | |
| 2023-12-20 | Sale | Buller Richard E | director | 350 0.0015% | $14.37 | $5,030 | +10.28% | |
| 2023-12-15 | Sale | Dalvey David | director | 2,940 0.0121% | $14.57 | $42,847 | +7.43% | |
| 2023-12-14 | Sale | Dalvey David | director | 5,000 0.0206% | $14.75 | $73,752 | +6.71% | |
| 2023-12-13 | Sale | Dalvey David | director | 5,000 0.0202% | $14.50 | $72,500 | +6.64% | |
| 2023-12-12 | Sale | Dalvey David | director | 2,060 0.0085% | $14.61 | $30,089 | +7.49% | |
| 2023-12-08 | Sale | Dalvey David | director | 5,000 0.0207% | $15.00 | $75,000 | +5.43% | |
| 2023-12-07 | Sale | Dalvey David | director | 5,000 0.0207% | $14.85 | $74,250 | +5.95% | |
| 2023-10-25 | Sale | Buller Richard E | director | 350 0.0016% | $10.23 | $3,581 | +50.12% | |
| 2023-08-30 | Sale | Buller Richard E | director | 350 0.0015% | $9.28 | $3,248 | +53.85% | |
| 2023-08-23 | Sale | Buller Richard E | director | 300 0.0013% | $9.82 | $2,946 | +43.91% | |
| 2023-06-23 | Sale | Buller Richard E | director | 300 0.0014% | $11.79 | $3,537 | +25.91% | |
| 2023-05-23 | Sale | Buller Richard E | director | 75 0.0003% | $11.10 | $833 | +20.73% | |
| 2023-05-22 | Sale | Buller Richard E | director | 100 0.0005% | $10.50 | $1,050 | +24.01% | |
| 2023-05-22 | Furcht Leo | director | 10,000 0.0449% | $10.32 | $103,187 | +24.01% | ||
| 2023-05-19 | Sale | Buller Richard E | director | 250 0.0011% | $9.85 | $2,463 | +25.54% | |
| 2023-04-21 | Sale | Buller Richard E | director | 300 0.0014% | $9.70 | $2,910 | +12.90% | |
| 2023-02-21 | Sale | Buller Richard E | director | 300 0.0014% | $11.40 | $3,420 | -9.18% |
Insider Historical Profitability
| Dalvey David | director | 225000 0.9296% | $16.03 | 0 | 6 | |
| Buller Richard E | director | 7381 0.0348% | $16.03 | 0 | 24 | |
| Sullivan Brian F. | Chief Executive Officer | 3016643 12.4638% | $16.03 | 1 | 0 | +9.38% |
| NIGON RICHARD | director | 96032 0.3968% | $16.03 | 7 | 0 | +17.9% |
| Furcht Leo | director | 10250 0.0423% | $16.03 | 1 | 0 | +24.01% |
| Murphy Polly A. | director | 5000 0.0207% | $16.03 | 1 | 0 | +10.68% |
Institutional Investor Ownership
| Perceptive Advisors | $51.03M | 7.56 | 2.36M | +59.47% | +$19.03M | 0.03 | |
| Morgan Stanley | $50.75M | 7.52 | 2.35M | +7.02% | +$3.33M | <0.01 | |
| Soleus Capital Management, L.P. | $37.4M | 5.54 | 1.73M | -20.56% | -$9.68M | 0.36 | |
| Commodore Capital, LP | $33.61M | 4.98 | 1.56M | -11.33% | -$4.29M | 2.37 | |
| Baker Bros Advisors LP | $33.53M | 4.97 | 1.55M | +189.92% | +$21.97M | 0.42 | |
| Eventide Asset Management | $30.02M | 4.45 | 1.39M | New | +$30.02M | 0.47 | |
| Nea Management Company Llc | $27M | 4 | 1.25M | 0% | +$0 | 0.31 | |
| BlackRock | $24.02M | 3.56 | 1.11M | +5.85% | +$1.33M | <0.01 | |
| Vr Adviser Llc | $20.95M | 3.11 | 970,000 | -48.56% | -$19.78M | 1.02 | |
| Balyasny Asset Management Llc | $19.05M | 2.82 | 881,934 | New | +$19.05M | 0.05 | |
| The Vanguard Group | $17.9M | 2.65 | 828,597 | +0.95% | +$168,933.60 | <0.0001 | |
| Samlyn Capital, LLC | $14.9M | 2.21 | 689,763 | New | +$14.9M | 0.26 | |
| Adage Capital Partners Gp L L C | $14.21M | 2.11 | 658,000 | New | +$14.21M | 0.03 | |
| PFM Health Sciences | $10.74M | 1.59 | 497,002 | +216.57% | +$7.34M | 0.3 | |
| CAPTRUST | $10.09M | 1.5 | 467,245 | -14.24% | -$1.68M | <0.01 | |
| Geode Capital Management | $7.55M | 1.12 | 349,722 | +8.13% | +$568,004.52 | <0.01 | |
| Verition Fund Management Llc | $7.43M | 1.1 | 343,984 | New | +$7.43M | 0.08 | |
| State Street | $7.27M | 1.08 | 336,540 | +13.44% | +$861,472.80 | <0.0001 | |
| ExodusPoint Capital Management, LP | $7.09M | 1.05 | 328,064 | New | +$7.09M | 0.09 | |
| Ameriprise Financial | $6.54M | 0.97 | 302,863 | +7.08% | +$432,410.35 | <0.01 | |
| Bank of America | $5.19M | 0.77 | 240,504 | +1,121.76% | +$4.77M | <0.01 | |
| Invesco | $4.22M | 0.63 | 195,335 | -6.64% | -$300,067.20 | <0.01 | |
| Northern Trust | $4.1M | 0.61 | 189,758 | +3.59% | +$141,912.01 | <0.01 | |
| Healthcare Of Ontario Pension Plan Trust Fund | $3.54M | 0.53 | 164,100 | New | +$3.54M | 0.01 | |
| Driehaus Capital Management LLC | $2.72M | 0.4 | 126,067 | New | +$2.72M | 0.03 | |
| Citadel Advisors LLC | $2.63M | 0.39 | 121,830 | +357.83% | +$2.06M | <0.01 | |
| Marshall Wace | $2.35M | 0.35 | 108,815 | New | +$2.35M | <0.01 | |
| Millennium Management LLC | $1.93M | 0.29 | 89,275 | New | +$1.93M | <0.01 | |
| Renaissance Technologies | $1.62M | 0.24 | 74,856 | +187.29% | +$1.05M | <0.01 | |
| JPMorgan Chase | $1.28M | 0.19 | 59,114 | +246.79% | +$908,668.52 | <0.0001 | |
| Gagnon Securities | $1.16M | 0.17 | 53,530 | -0.89% | -$10,368.00 | 0.29 | |
| Cunning Capital Partners Lp | $2.36M | 0.17 | 52,465 | New | +$2.36M | 1.34 | |
| UBS | $1.07M | 0.16 | 49,307 | -6.69% | -$76,334.39 | <0.0001 | |
| BNY Mellon | $1M | 0.15 | 46,445 | -11.46% | -$129,837.60 | <0.0001 | |
| Charles Schwab | $978,761.00 | 0.15 | 45,313 | +0.08% | +$777.60 | <0.0001 | |
| Two Sigma | $955,174.00 | 0.14 | 44,221 | New | +$955,174.00 | <0.01 | |
| Zuraw Financial Advisors LLC | $822,766.00 | 0.12 | 38,091 | 0% | +$0 | 0.09 | |
| Connor Clark & Lunn Investment Management Ltd | $809,849.00 | 0.12 | 37,493 | New | +$809,849.00 | <0.01 | |
| Jump Financial Llc | $788,249.00 | 0.12 | 36,493 | New | +$788,249.00 | 0.01 | |
| Nuveen | $700,726.00 | 0.1 | 32,441 | 0% | +$0 | <0.0001 | |
| J. Goldman & Company | $694,894.00 | 0.1 | 32,171 | -71.08% | -$1.71M | 0.03 | |
| Jane Street Capital | $669,298.00 | 0.1 | 30,986 | New | +$669,298.00 | <0.01 | |
| Accredited Investors Inc | $628,884.00 | 0.09 | 29,115 | 0% | +$0 | 0.04 | |
| RhumbLine Advisers | $548,959.00 | 0.08 | 25,415 | +8.61% | +$43,502.00 | <0.01 | |
| Walleye Capital | $544,774.00 | 0.08 | 25,221 | New | +$544,774.00 | <0.01 | |
| Wealth Enhancement Advisory Services LLC | $441,292.00 | 0.07 | 20,430 | +2.99% | +$12,808.92 | <0.01 | |
| Cresset Asset Management Llc | $399,816.00 | 0.06 | 18,510 | 0% | +$0 | <0.01 | |
| Dimensional Fund Advisors | $386,705.00 | 0.06 | 17,903 | 0% | +$0 | <0.0001 | |
| Two Sigma Advisers LP | $328,320.00 | 0.05 | 15,200 | New | +$328,320.00 | <0.01 | |
| Barclays | $277,000.00 | 0.04 | 12,844 | -46.53% | -$241,048.66 | <0.0001 |